New EU Health Commissioner appointed amid controversy,The Lancet

当前位置： X-MOL 学术 › Lancet › 论文详情

Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)

New EU Health Commissioner appointed amid controversy
The Lancet ( IF 98.4 ) Pub Date : 2024-12-12 , DOI: 10.1016/s0140-6736(24)02709-0
Marianne Guenot

Section snippets

A tumultuous appointment process

Várhelyi's designation by von der Leyen was met by fierce opposition, mainly emerging from the Progressive Alliance of Socialists and Democrats and Renew Europe political groups. MEPs raised concerns about Hungary's approach to the COVID-19 vaccines—the only country to provide vaccines not approved by the European Medicines Agency (EMA) during the pandemic—as well as the country's restrictive approach to sexual and reproductive rights. Várhelyi repeated his belief in the safety and efficacy of

Keeping EU health on the agenda

European Commissioners do not vote in laws, but they do hold strategic positions as they draw up the proposals for legislative texts, help set EU spending priorities, draw up budget proposals, enforce EU legislation, and implement the EU budget.Health, which has historically been a less pressing agenda on the EU level, has gained a lot of momentum in recent years, accelerated by the COVID-19 pandemic. In March, 2021, member states notably increased the budget of the health programme EU4Health

Big legislative moves upcoming

With his appointment, Várhelyi will be facing some important legislative negotiations. He is in charge of bringing the proposal for the Critical Medicines Act forward. This new EU mechanism will aim to end the reliance of the EU medicine supply on external suppliers, most notably Asia. The mechanism is expected to support the production of active pharmaceutical ingredients and finished medicines in Europe—a tall order in the EU's fragmented market. “It's a sensitive issue”, said de Ruijter,

更新日期：2024-12-12

点击分享查看原文

点击收藏

阅读更多本刊新发论文